A detailed history of Aqr Capital Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Aqr Capital Management LLC holds 871,196 shares of ABT stock, worth $98.8 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
871,196
Previous 832,520 4.65%
Holding current value
$98.8 Million
Previous $94.6 Million 4.33%
% of portfolio
0.14%
Previous 0.16%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $3.9 Million - $4.35 Million
38,676 Added 4.65%
871,196 $90.5 Million
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $3.19 Million - $3.53 Million
29,160 Added 3.63%
832,520 $94.6 Million
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $25.2 Million - $30.8 Million
-278,909 Reduced 25.77%
803,360 $88.4 Million
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $10.8 Million - $13 Million
-113,358 Reduced 9.48%
1,082,269 $105 Million
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $45.7 Million - $50.9 Million
-453,281 Reduced 27.49%
1,195,627 $130 Million
Q1 2023

May 15, 2023

SELL
$96.86 - $114.01 $15.7 Million - $18.5 Million
-162,069 Reduced 8.95%
1,648,908 $167 Million
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $13.3 Million - $15.5 Million
139,394 Added 8.34%
1,810,977 $199 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $17.7 Million - $20.5 Million
-182,643 Reduced 9.85%
1,671,583 $162 Million
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $2.92 Million - $3.53 Million
-28,635 Reduced 1.52%
1,854,226 $200 Million
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $2.95 Million - $3.6 Million
-25,868 Reduced 1.36%
1,882,861 $223 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $9.56 Million - $11.7 Million
-82,775 Reduced 4.16%
1,908,729 $269 Million
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $12.2 Million - $13.5 Million
-104,884 Reduced 5.0%
1,991,504 $235 Million
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $22.6 Million - $26.6 Million
-213,605 Reduced 9.25%
2,096,388 $243 Million
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $69.5 Million - $81.9 Million
638,726 Added 38.22%
2,309,993 $277 Million
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $38.5 Million - $41.9 Million
366,431 Added 28.08%
1,671,267 $181 Million
Q3 2020

Nov 16, 2020

BUY
$91.64 - $111.29 $25.4 Million - $30.9 Million
277,685 Added 27.03%
1,304,836 $138 Million
Q2 2020

Aug 17, 2020

BUY
$76.57 - $98.0 $32.9 Million - $42.2 Million
430,235 Added 72.08%
1,027,151 $91.2 Million
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $18.2 Million - $26.6 Million
-289,276 Reduced 32.64%
596,916 $47.1 Million
Q4 2019

Feb 14, 2020

SELL
$78.51 - $87.4 $42.5 Million - $47.3 Million
-541,184 Reduced 37.91%
886,192 $77 Million
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $61.4 Million - $66.6 Million
-750,271 Reduced 34.45%
1,427,376 $119 Million
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $10.2 Million - $11.9 Million
139,598 Added 6.85%
2,177,647 $182 Million
Q1 2019

May 14, 2019

BUY
$66.22 - $80.06 $3.08 Million - $3.72 Million
46,449 Added 2.33%
2,038,049 $162 Million
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $49.7 Million - $56.3 Million
757,437 Added 61.37%
1,991,600 $144 Million
Q3 2018

Nov 15, 2018

BUY
$60.81 - $73.36 $17.4 Million - $21 Million
286,021 Added 30.17%
1,234,163 $90.5 Million
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $24.3 Million - $26.9 Million
422,853 Added 80.5%
948,142 $57.8 Million
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $6.47 Million - $7.31 Million
114,895 Added 28.0%
525,289 $31.5 Million
Q4 2017

Feb 14, 2018

BUY
$53.68 - $57.47 $17 Million - $18.2 Million
317,078 Added 339.79%
410,394 $23.4 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $4.48 Million - $5.01 Million
93,316
93,316 $4.98 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.